These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7671550

  • 1. Effects of in vivo and in vitro insulin on renal 25 (OH) D3 hydroxylation in insulin dependent diabetic rats.
    Weaver VM, Welsh JE.
    Diabetes Res; 1994; 25(3):107-19. PubMed ID: 7671550
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Effects of dietary calcium restriction on 1,25-dihydroxyvitamin D3 net synthesis by rat proximal tubules.
    Langman CB, Favus MJ, Bushinsky DA, Coe FL.
    J Lab Clin Med; 1985 Sep; 106(3):286-92. PubMed ID: 2993458
    [Abstract] [Full Text] [Related]

  • 4. [Metabolism of 25-hydroxyvitamin D3 and its regulation in rats during hypokinesis].
    Sergeev IN, Arkhapchev IuP, Linberg LF, Blazheevich NV, Ushakov AS.
    Biokhimiia; 1984 Apr; 49(4):590-8. PubMed ID: 6329324
    [Abstract] [Full Text] [Related]

  • 5. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
    Astecker N, Bobrovnikova EA, Omdahl JL, Gennaro L, Vouros P, Schuster I, Uskokovic MR, Ishizuka S, Wang G, Reddy GS.
    Arch Biochem Biophys; 2004 Nov 15; 431(2):261-70. PubMed ID: 15488475
    [Abstract] [Full Text] [Related]

  • 6. Tissue ascorbic acid and polyol pathway metabolism in experimental diabetes.
    Lindsay RM, Jamieson NS, Walker SA, McGuigan CC, Smith W, Baird JD.
    Diabetologia; 1998 May 15; 41(5):516-23. PubMed ID: 9628267
    [Abstract] [Full Text] [Related]

  • 7. The number of 1,25-dihydroxyvitamin D3 receptors is decreased in both intestine and kidney of genetically diabetic db/db mice.
    Ishida H, Cunningham NS, Henry HL, Norman AW.
    Endocrinology; 1988 Jun 15; 122(6):2436-43. PubMed ID: 2836163
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D receptors in intestine, kidney and thymus of streptozotocin diabetic rats.
    Stone LA, Weaver VM, Bruns ME, Welsh J.
    Diabetes Res; 1990 Dec 15; 15(4):165-72. PubMed ID: 1966737
    [Abstract] [Full Text] [Related]

  • 9. Altered phosphorylation of a 91-kDa protein in particulate fractions of rat kidney after protracted 1,25-dihydroxyvitamin D3 or estrogen treatment.
    Qin X, Siaw EK, Cheung A, Walters MR.
    Arch Biochem Biophys; 1997 Dec 15; 348(2):239-46. PubMed ID: 9434734
    [Abstract] [Full Text] [Related]

  • 10. Plasma 1,25(OH)2D3 response to parathyroid hormone, cyclic adenosine monophosphate, and phosphorus depletion in the spontaneously hypertensive rat.
    Young EW, Patel SR, Hsu CH.
    J Lab Clin Med; 1986 Dec 15; 108(6):562-6. PubMed ID: 3023510
    [Abstract] [Full Text] [Related]

  • 11. Insulin modulates the stimulation of renal 1,25-dihydroxyvitamin D3 production by parathyroid hormone.
    Wongsurawat N, Armbrecht HJ.
    Acta Endocrinol (Copenh); 1985 Jun 15; 109(2):243-8. PubMed ID: 3893009
    [Abstract] [Full Text] [Related]

  • 12. Effects of hypophysectomy and growth hormone treatment on renal hydroxylation of 25-hydroxycholecalciferol in rats.
    Wongsurawat N, Armbrecht HJ, Zenser TV, Forte LR, Davis BB.
    J Endocrinol; 1984 Jun 15; 101(3):333-8. PubMed ID: 6610018
    [Abstract] [Full Text] [Related]

  • 13. Impaired parathyroid hormone action on urinary phosphorus excretion in isolated perfused kidney of streptozotocin-induced diabetic rats.
    Mokuda O, Sakamoto Y.
    Horm Metab Res; 1999 Oct 15; 31(10):543-5. PubMed ID: 10596962
    [Abstract] [Full Text] [Related]

  • 14. Metabolism of 1,25-dihydroxyvitamin D3.
    Kumar R.
    Physiol Rev; 1984 Apr 15; 64(2):478-504. PubMed ID: 6324253
    [Abstract] [Full Text] [Related]

  • 15. Changes of vitamin D3 serum concentrations at the onset of immune-mediated type 1 (insulin-dependent) diabetes mellitus.
    Baumgartl HJ, Standl E, Schmidt-Gayk H, Kolb HJ, Janka HU, Ziegler AG.
    Diabetes Res; 1991 Mar 15; 16(3):145-8. PubMed ID: 1666347
    [Abstract] [Full Text] [Related]

  • 16. Alterations in femoral bone histomorphometry and vitamin D metabolism in neonatal streptozotocin-induced diabetic rat.
    Umeda F, Inoue K, Hirano K, Mimura K, Watanabe J, Haji M, Sueishi K, Nawata H.
    Fukuoka Igaku Zasshi; 1992 Nov 15; 83(11):403-8. PubMed ID: 1336471
    [Abstract] [Full Text] [Related]

  • 17. 1,25(OH)2D3 and Ca-binding protein in fetal rats: relationship to the maternal vitamin D status.
    Verhaeghe J, Thomasset M, Bréhier A, Van Assche FA, Bouillon R.
    Am J Physiol; 1988 Apr 15; 254(4 Pt 1):E505-12. PubMed ID: 3354665
    [Abstract] [Full Text] [Related]

  • 18. Diabetes and renal calcium binding protein in the rat.
    Schedl HP, Christakos S, Wilson HD, Malkowitz L, Horst RL.
    Proc Soc Exp Biol Med; 1984 Oct 15; 177(1):176-9. PubMed ID: 6382269
    [Abstract] [Full Text] [Related]

  • 19. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M, Kremer R, Goltzman D, Rabbani SA.
    J Clin Invest; 1993 Jun 15; 91(6):2416-22. PubMed ID: 8514854
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo inhibition of mTOR by 1,25-dihydroxyvitamin D3 to improve early diabetic nephropathy via the DDIT4/TSC2/mTOR pathway.
    Wang H, Wang J, Qu H, Wei H, Ji B, Yang Z, Wu J, He Q, Luo Y, Liu D, Duan Y, Liu F, Deng H.
    Endocrine; 2016 Nov 15; 54(2):348-359. PubMed ID: 27395420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.